Industry News
Pharmaceutical Industry News
Pfizer’s COVID-19 booster application set for high-stakes FDA advisory committee review in two weeks
Pfizer's COVID-19 booster application set for high-stakes FDA advisory committee review in two weeks esagonowsky Thu, 09/02/2021 - 09:27
Pfizer’s COVID-19 booster application set for high-stakes FDA advisory committee review in 2 weeks
Pfizer's COVID-19 booster application set for high-stakes FDA advisory committee review in 2 weeks esagonowsky Thu, 09/02/2021 - 09:27
Quotient Sciences casts $8.7M spell over its new Alnwick facility, adding drug substance capacity and 80 jobs
Quotient Sciences casts $8.7M spell over its new Alnwick facility, adding drug substance capacity and 80 jobs nhigginsdunn Thu, 09/02/2021 - 08:47
FDA’s new JAK safety restrictions spell trouble for AbbVie’s Rinvoq, but to what extent?
FDA's new JAK safety restrictions spell trouble for AbbVie's Rinvoq, but to what extent? aliu Thu, 09/02/2021 - 08:23
Joe Rogan, A Podcasting Giant Who Has Been Dismissive of Vaccination, Has Covid
“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series of shows in Florida.
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded FDA heart safety, cancer warnings
JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded FDA heart safety, cancer warnings aliu Wed, 09/01/2021 - 12:18
Biogen’s Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises
Biogen's Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises nhigginsdunn Wed, 09/01/2021 - 11:33
Sanofi pulls Epilim website after U.K. regulator points out consumer complaint
Sanofi pulls Epilim website after U.K. regulator points out consumer complaint bbulik Wed, 09/01/2021 - 11:33
Merck’s Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label
Merck's Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label aliu Wed, 09/01/2021 - 10:32
Moderna reveals source of COVID-19 vaccine contamination as Japan finds yet another suspect vial
Moderna reveals source of COVID-19 vaccine contamination as Japan finds yet another suspect vial kdunleavy Wed, 09/01/2021 - 09:30
CDMO ten23 health launches in Switzerland with financing from 3i Group and a focus on injectables
CDMO ten23 health launches in Switzerland with financing from 3i Group and a focus on injectables kdunleavy Wed, 09/01/2021 - 01:43
Novartis, NHS England move forward with ‘landmark’ access deal for cholesterol drug Leqvio
Novartis, NHS England move forward with 'landmark' access deal for cholesterol drug Leqvio esagonowsky Tue, 08/31/2021 - 14:34
Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera
Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera nhigginsdunn Tue, 08/31/2021 - 14:26
Merck, Amgen adopt double-digit price hikes in test to Big Pharma’s unofficial annual limits: analyst
Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst nhigginsdunn Tue, 08/31/2021 - 11:36
AbbVie’s Imbruvica patent win sets up solid growth path after Humira’s decline: analyst
AbbVie's Imbruvica patent win sets up solid growth path after Humira's decline: analyst kdunleavy Tue, 08/31/2021 - 11:27
Key vaccine leaders departing FDA as COVID-19 booster questions linger
Key vaccine leaders departing FDA as COVID-19 booster questions linger aarmstrong Tue, 08/31/2021 - 11:15
FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris Poll
FDA approval of Pfizer's COVID-19 vaccine spurs American confidence: Harris Poll bbulik Tue, 08/31/2021 - 10:49
Servier’s beefing up in oncology through dealmaking and Tibsovo wins—and it’s not done yet, U.S. CEO says
Servier's beefing up in oncology through dealmaking and Tibsovo wins—and it's not done yet, U.S. CEO says aliu Tue, 08/31/2021 - 10:15
CDC enlists comedian to embrace the awkwardness of gynecology visits—and encourage women to go
CDC enlists comedian to embrace the awkwardness of gynecology visits—and encourage women to go sharon.coey Tue, 08/31/2021 - 09:15